高级检索
曹荣月, 常娜, 李曼曼, 王云康, 吴迪, 时宝莹, 袁玉婷, 龙军. mGM-CSF/βhCG融合蛋白的制备及其致敏树突状细胞疫苗抗小鼠RM-1前列腺癌的作用[J]. 中国药科大学学报, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
引用本文: 曹荣月, 常娜, 李曼曼, 王云康, 吴迪, 时宝莹, 袁玉婷, 龙军. mGM-CSF/βhCG融合蛋白的制备及其致敏树突状细胞疫苗抗小鼠RM-1前列腺癌的作用[J]. 中国药科大学学报, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
shu
CAO Rongyue, CHANG Na, LI Manman, WANG Yunkang, WU Di, SHI Baoying, YUAN Yuting, LONG Jun. Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice[J]. Journal of China Pharmaceutical University, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
Citation: CAO Rongyue, CHANG Na, LI Manman, WANG Yunkang, WU Di, SHI Baoying, YUAN Yuting, LONG Jun. Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice[J]. Journal of China Pharmaceutical University, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
shu

mGM-CSF/βhCG融合蛋白的制备及其致敏树突状细胞疫苗抗小鼠RM-1前列腺癌的作用

Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice

    摘要
  • 摘要: 利用分子生物学方法设计并构建含有βhCG基因和mGM-CSF基因的表达载体pET-28a-mGM-CSF-X10-βhCGCTP37质粒。乳糖诱导表达该融合蛋白，通过硫酸铵分级沉淀和阴离子交换柱DEAE-cellulose进行纯化，并以此融合蛋白致敏从C57BL/6J小鼠体内提取的树突状细胞(DC)从而获得DC疫苗。将DC疫苗回输至接种前列腺癌RM-1的C57BL/6J小鼠体内，分组检测。结果显示，DC组和DC与紫杉醇(Pac)联用(DP)组与Pac组相比抗肿瘤效果具有极显著性差异(P<；0.01)；且DP组的抗肿瘤效果优于DC组。可见构建的新型DC疫苗可抑制前列腺癌的生长，且与紫杉醇联合使用具有协同抗肿瘤作用。

     

    Abstract: An expression vector pET-28a-mGM-CSF-X10-βhCGCTP37 plasmid containing the βhCG and mGM-CSF gene was designed and constructed. The fusion protein was induced by lactose and purified by ammonium sulfate precipitation and DEAE-cellulose anion exchange column. Then dendritic cells(DC)in C57BL/6J mice were extracted and sensitized by the fusion protein to obtain DC vaccine. The DC vaccine was inoculated to C57BL of / 6J mice with prostate cancer RM-1. The results indicated that the anti-tumor effects of DC group and DC combined with paclitaxel(DP)group were superior to that of paclitaxel(Pac)group(P< 0. 01), and the anti-tumor effect of DP group was better than that of DC group. Thus, the constructed DC vaccine can inhibit the growth of prostate cancer, and have synergistic anti-tumor when used with paclitaxel.

     

    • HTML全文
    • 参考文献(13)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回

访问量：